|
🐜
|
International uniform response criteria for multiple myeloma
31 auth.
B. Durie,
J. Harousseau,
J. Miguel,
J. Bladé,
B. Barlogie,
K. Anderson,
M. Gertz,
M. Dimopoulos,
J. Westin,
P. Sonneveld,
H. Ludwig,
G. Gahrton,
M. Beksaç,
J. Crowley,
A. Belch,
...
M. Boccadaro,
I. Turesson,
D. Joshua,
D. Vesole,
R. Kyle,
R. Alexanian,
G. Tricot,
M. Attal,
G. Merlini,
R. Powles,
P. Richardson,
K. Shimizu,
P. Tosi,
G. Morgan,
S. Rajkumar,
on behalf of the International Myeloma Working Group
|
11 |
2006 |
11
🐜
|
|
🐜
|
Review of 1027 patients with newly diagnosed multiple myeloma.
13 auth.
Robert A. Kyle,
M. Gertz,
T. Witzig,
J. Lust,
M. Lacy,
A. Dispenzieri,
R. Fonseca,
S. Rajkumar,
J. Offord,
Dirk R Larson,
...
Matthew E. Plevak,
Terry M. Therneau,
P. Greipp
|
11 |
2003 |
11
🐜
|
|
🐢
|
Improved survival in multiple myeloma and the impact of novel therapies.
13 auth.
Shaji K. Kumar,
S. Rajkumar,
A. Dispenzieri,
M. Lacy,
S. Hayman,
F. Buadi,
S. Zeldenrust,
D. Dingli,
S. Russell,
J. Lust,
...
P. Greipp,
R. Kyle,
M. Gertz
|
11 |
2008 |
11
🐢
|
|
🐜
|
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
10 auth.
J. Bladé,
D. Samson,
D. Reece,
J. Apperley,
B. Björkstrand,
G. Gahrton,
...
M. Gertz,
S. Giralt,
S. Jagannath,
D. Vesole
|
10 |
1998 |
10
🐜
|
|
🦁
|
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
13 auth.
M. Gertz,
R. Comenzo,
R. Falk,
J. Fermand,
B. Hazenberg,
P. Hawkins,
G. Merlini,
P. Moreau,
P. Ronco,
V. Sanchorawala,
...
O. Sezer,
A. Solomon,
G. Grateau
|
10 |
2005 |
10
🦁
|
|
🐜
|
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
17 auth.
Shaji K. Kumar,
A. Dispenzieri,
M. Lacy,
M. Gertz,
F. Buadi,
Shivlal Pandey,
P. Kapoor,
D. Dingli,
S. Hayman,
N. Leung,
...
J. Lust,
A. McCurdy,
S. Russell,
S. Zeldenrust,
R. Kyle,
S. Vincent Rajkumar,
Shaji K. Kumar
|
10 |
2013 |
10
🐜
|
|
🐢
|
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
R. Kyle,
M. Gertz
|
10 |
1995 |
10
🐢
|
|
🐢
|
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
16 auth.
Shaji K. Kumar,
A. Dispenzieri,
M. Lacy,
S. Hayman,
F. Buadi,
C. Colby,
K. Laumann,
S. Zeldenrust,
N. Leung,
D. Dingli,
...
P. Greipp,
J. Lust,
S. Russell,
R. Kyle,
S. Rajkumar,
M. Gertz
|
9 |
2012 |
9
🐢
|
|
🐜
|
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.
14 auth.
A. Dispenzieri,
M. Gertz,
R. Kyle,
M. Lacy,
M. Burritt,
T. Therneau,
P. Greipp,
T. Witzig,
J. Lust,
S. Rajkumar,
...
R. Fonseca,
S. Zeldenrust,
Christopher G.A. McGregor,
A. Jaffe
|
9 |
2004 |
9
🐜
|
|
🐜
|
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
14 auth.
G. Palladini,
A. Dispenzieri,
M. Gertz,
Shaji K. Kumar,
A. Wechalekar,
P. Hawkins,
S. Schönland,
U. Hegenbart,
R. Comenzo,
E. Kastritis,
...
M. Dimopoulos,
A. Jaccard,
C. Klersy,
G. Merlini
|
9 |
2012 |
9
🐜
|
|
🐜
|
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
33 auth.
A. Dispenzieri,
R. Kyle,
G. Merlini,
J. Miguel,
H. Ludwig,
R. Hájek,
A. Palumbo,
S. Jagannath,
J. Bladé,
S. Lonial,
M. Dimopoulos,
R. Comenzo,
H. Einsele,
B. Barlogie,
K. Anderson,
...
M. Gertz,
J. Harousseau,
M. Attal,
P. Tosi,
P. Sonneveld,
M. Boccadoro,
G. Morgan,
P. Richardson,
O. Sezer,
M. Mateos,
M. Cavo,
D. Joshua,
I. Turesson,
Wenming Chen,
K. Shimizu,
R. Powles,
S. Rajkumar,
B. Durie
|
9 |
2009 |
9
🐜
|
|
🐢
|
POEMS syndrome: definitions and long-term outcome.
13 auth.
A. Dispenzieri,
R. Kyle,
M. Lacy,
S. Rajkumar,
T. Therneau,
D. Larson,
P. Greipp,
T. Witzig,
R. Basu,
Guillermo A. Suarez,
...
R. Fonseca,
J. Lust,
M. Gertz
|
9 |
2003 |
9
🐢
|
|
🐜
|
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
35 auth.
M. Benson,
M. Waddington-Cruz,
J. Berk,
M. Polydefkis,
P. Dyck,
Annabel K. Wang,
V. Planté-Bordeneuve,
F. Barroso,
G. Merlini,
L. Obici,
M. Scheinberg,
T. Brannagan,
W. Litchy,
C. Whelan,
B. Drachman,
...
D. Adams,
S. Heitner,
I. Conceição,
H. Schmidt,
G. Vita,
J. Campistol,
J. Gámez,
P. Gorevic,
E. Gane,
A. Shah,
S. Solomon,
B. Monia,
S. Hughes,
J. Kwoh,
B. McEvoy,
Shiangtung W. Jung,
B. Baker,
E. Ackermann,
M. Gertz,
T. Coelho
|
9 |
2018 |
9
🐜
|
|
🐜
|
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
7 auth.
R. Kyle,
M. Gertz,
P. Greipp,
T. Witzig,
J. Lust,
M. Lacy,
...
T. Therneau
|
9 |
1997 |
9
🐜
|
